Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
GLP-1 receptor agonist initiation and newly recorded ankylosing spondylitis diagnoses in type 2 diabetes: a target trial emulation
Related
- Associations of mortality and sepsis after GLP-1 receptor agonist initiation versus SGLT2 inhibitor or metformin initiation in people with HIV, overweight or obesity, and type 2 diabetes: A target trial emulation
- Adalimumab-induced pustular psoriasis successfully treated with tofacitinib in a patient with ankylosing spondylitis: A brief report.
- Ultrasound-guided Interscalene Block as a Safer Alternative to General Anesthesia in a Patient with Ankylosing Spondylitis Undergoing Proximal Humerus Fracture Fixation
- Case Report: Spinal cord herniation associated with ankylosing spondylitis
- Successful extravascular implantable cardioverter defibrillator implantation in a patient with ankylosing spondylitis and severe thoracic deformity: a case report.
BibTeX
@article{lu2026glp1,
title = {{GLP-1 receptor agonist initiation and newly recorded ankylosing spondylitis diagnoses in type 2 diabetes: a target trial emulation}},
author = {Yu-Chen Lu and Tzu-Hao Li and Ya-Fang Liu and Ming-Hsien Tsai},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-75731-6},
url = {https://www.nature.com/articles/s41598-026-75731-6},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - GLP-1 receptor agonist initiation and newly recorded ankylosing spondylitis diagnoses in type 2 diabetes: a target trial emulation
AU - Yu-Chen Lu
AU - Tzu-Hao Li
AU - Ya-Fang Liu
AU - Ming-Hsien Tsai
PY - 2026
DA - 2026/10/20
JO - Scientific Reports
DO - 10.1038/s41598-026-75731-6
UR - https://www.nature.com/articles/s41598-026-75731-6
SN - 2045-2322
ER -